Stuart Colligon, Chairman

Stuart has worked in senior positions in the health sector since 1998. He has been in the international pharmaceutical industry for 16 years, during which time he founded and established Panacea in 2008. His experience in the pharma industry has been built in the development and supply chain phases, and his entire career has been immersed in service provision. Stuart is committed to establishing excellent, honest and mutually rewarding partnerships within Panacea and with Panacea’s clients, and his service sector background ensures that this is a natural element of Panacea’s culture. Having set up and run several successful businesses, he gives Panacea the grounding to grow confidently to ensure that it will be a long-term, sustainable partner of choice for the best companies in the industry.

stewart_mbl

Stuart Colligon, Chairman

Stuart has worked in senior positions in the health sector since 1998. He has been in the international pharmaceutical industry for 16 years, during which time he founded and established Panacea in 2008. His experience in the pharma industry has been built in the development and supply chain phases, and his entire career has been immersed in service provision. Stuart is committed to establishing excellent, honest and mutually rewarding partnerships within Panacea and with Panacea’s clients, and his service sector background ensures that this is a natural element of Panacea’s culture. Having set up and run several successful businesses, he gives Panacea the grounding to grow confidently to ensure that it will be a long-term, sustainable partner of choice for the best companies in the industry.

Anne Buchanan, Finance Director

Before joining Panacea in 2009, Anne worked for a Global Corporate Service Provider. Anne progressed through Senior Management roles within Panacea before joining the Board of Directors in January 2015. Having both an accounting qualification, alongside her qualification with the renowned Institute of Directors, Anne’s financial background combined with strategic thinking, ensures that the Board have the vital financial input required to keep Panacea on its continued growth curve.

anne_mbl

Anne Buchanan, Finance Director

Before joining Panacea in 2009, Anne worked for a Global Corporate Service Provider. Anne progressed through Senior Management roles within Panacea before joining the Board of Directors in January 2015. Having both an accounting qualification, alongside her qualification with the renowned Institute of Directors, Anne’s financial background combined with strategic thinking, ensures that the Board have the vital financial input required to keep Panacea on its continued growth curve.

Craig Wolstencroft, Non Executive Director

Craig is a successful entrepreneur based in the Isle of Man having founded one of the Isle of Man`s most respected professional communication agencies. Craig brings valuable input to Panacea’s Board with his sound strategic thinking and ability to both advise and deploy progressive thinking at a senior business level. Craig is an exceptional leader with a talent at getting the best out of a team and leading from the front. Craig is also very Tech-savvy with solid relationship building and presentation skills. Being a motivated multi business owner himself, Craig has experience with experience at managing all levels.

craig_mbl

Craig Wolstencroft, Non Executive Director

Craig is a successful entrepreneur based in the Isle of Man having founded one of the Isle of Man`s most respected professional communication agencies. Craig brings valuable input to Panacea’s Board with his sound strategic thinking and ability to both advise and deploy progressive thinking at a senior business level. Craig is an exceptional leader with a talent at getting the best out of a team and leading from the front. Craig is also very Tech-savvy with solid relationship building and presentation skills. Being a motivated multi business owner himself, Craig has experience with experience at managing all levels.

John Bingham, Non Executive Director

John is originally from Northern Ireland and now lives in the Isle of Man. John joined the Board of Panacea in 2011. He is a Fellow of the Chartered Institute of Bankers. His 20 year career in banking included heading up the international division of one of the UK’s largest financial institutions. He has expertise in leading teams through company restructuring and business development. John also worked as a consultant with the Isle of Man Government in helping to develop the jurisdiction and enhance the Isle of Man as a place of choice for international business.  Currently John is the owner of an Isle of Man based Trust Company and he is Chairman of Geodrill Limited, a publically quoted company listed on the Toronto Stock Exchange. John’s business experience has been a valuable contribution in the process of developing the strategic direction which has contributed to Panacea’s continued growth pattern.

john_mbl

John Bingham, Non Executive Director

John is originally from Northern Ireland and now lives in the Isle of Man. John joined the Board of Panacea in 2011. He is a Fellow of the Chartered Institute of Bankers. His 20 year career in banking included heading up the international division of one of the UK’s largest financial institutions. He has expertise in leading teams through company restructuring and business development. John also worked as a consultant with the Isle of Man Government in helping to develop the jurisdiction and enhance the Isle of Man as a place of choice for international business.  Currently John is the owner of an Isle of Man based Trust Company and he is Chairman of Geodrill Limited, a publically quoted company listed on the Toronto Stock Exchange. John’s business experience has been a valuable contribution in the process of developing the strategic direction which has contributed to Panacea’s continued growth pattern.

Sally Francis, Senior QPPV

Sally joined Panacea in August 2011 as QPPV.  Sally is a qualified midwife and moved into the area of Pharmacovigilance over ten years ago. Her experience  comes from working in two large global innovator pharmaceutical companies and one small UK generic company and includes post-marketing, clinical trials and devices. Sally was a member of the PIPA Signal Detection Working Party, which has now evolved into the new Benefit-Risk Management Working Party. She has been on both sides of the auditing table having successfully led clients through MHRA inspections and carrying out audits of prospective clients on behalf of Panacea.

sally_mbl

Sally Francis, Senior QPPV

Sally joined Panacea in August 2011 as QPPV.  Sally is a qualified midwife and moved into the area of Pharmacovigilance over ten years ago. Her experience  comes from working in two large global innovator pharmaceutical companies and one small UK generic company and includes post-marketing, clinical trials and devices. Sally was a member of the PIPA Signal Detection Working Party, which has now evolved into the new Benefit-Risk Management Working Party. She has been on both sides of the auditing table having successfully led clients through MHRA inspections and carrying out audits of prospective clients on behalf of Panacea.

Anne Dougherty, Head of Pharmacovigilance

Anne has worked in the pharmaceutical industry for over 13 years in both pharmacovigilance and regulatory affairs. She graduated with a BSc(Hons) in Biochemistry and went on to gain the Postgraduate Diploma in Pharmacovigilance whilst working at Pharmacia and Upjohn in 1999. Her experience in Pharmacovigilance is from both clinical trial and post marketing adverse event reporting including provision of medical information and assistance in product launches. She has been involved in inspections from both the MHRA and FDA and has successfully lead clients through the process of audit and inspection. Anne’s role as Head of Pharmacovigilance at Panacea is intended to ensure that the procedures in place are adhered to and that Panacea provides a quality of service to its clients acceptable to any inspecting authority.

anned_mbl

Anne Dougherty, Head of Pharmacovigilance

Anne has worked in the pharmaceutical industry for over 13 years in both pharmacovigilance and regulatory affairs. She graduated with a BSc(Hons) in Biochemistry and went on to gain the Postgraduate Diploma in Pharmacovigilance whilst working at Pharmacia and Upjohn in 1999. Her experience in Pharmacovigilance is from both clinical trial and post marketing adverse event reporting including provision of medical information and assistance in product launches. She has been involved in inspections from both the MHRA and FDA and has successfully lead clients through the process of audit and inspection. Anne’s role as Head of Pharmacovigilance at Panacea is intended to ensure that the procedures in place are adhered to and that Panacea provides a quality of service to its clients acceptable to any inspecting authority.

Helen Lowe, Head of Quality

Helen joined Panacea in February 2015.  She has worked in the pharmaceutical industry for twelve years in pharmacovigilance, quality and auditing roles.  As an auditor she has been involved with clinical trial site audits, pharmacovigilance audits and inspection preparation.  Within her latest roles she has been involved in the planning, implementing and preparation for audits and planning and preparation for inspections for numerous regulatory authorities including the MHRA and FDA.

helen_mbl

Helen Lowe, Head of Quality

Helen joined Panacea in February 2015.  She has worked in the pharmaceutical industry for twelve years in pharmacovigilance, quality and auditing roles.  As an auditor she has been involved with clinical trial site audits, pharmacovigilance audits and inspection preparation.  Within her latest roles she has been involved in the planning, implementing and preparation for audits and planning and preparation for inspections for numerous regulatory authorities including the MHRA and FDA.

Dr Liezl Schonken, Safety Physician

Liezl is responsible for the medical review of our clients’ pharmacovigilance documents and processes. Liezl’s commitment to consistently provide sound medical opinions and reviews allows the pharmacovigilance team and most importantly, our clients to feel secure and confident that every aspect has been covered. Through Panacea’s variety of clients, Liezl is involved in the medical review of many therapeutic areas, giving our clients a breadth of experience to call upon. Liezl is a GMC registered physician.

lizel_mbl

Dr Liezl Schonken, Safety Physician

Liezl is responsible for the medical review of our clients’ pharmacovigilance documents and processes. Liezl’s commitment to consistently provide sound medical opinions and reviews allows the pharmacovigilance team and most importantly, our clients to feel secure and confident that every aspect has been covered. Through Panacea’s variety of clients, Liezl is involved in the medical review of many therapeutic areas, giving our clients a breadth of experience to call upon. Liezl is a GMC registered physician.

Sam Tipper, Business Development Manager

Having joined Panacea in 2010, Sam’s role sees him developing the client relationships that Panacea are well-known for. With experience in a variety of roles at Panacea, Sam is uniquely placed to communicate on both a commercial and technical basis with clients. His ability to speak in plain language and understand detailed requirements, ensures that Panacea delivers on-time, every-time and maintains its current reputation as the leading, quality-focussed, pharmacovigilance and regulatory affairs provider.

sam_mbl

Sam Tipper, Business Development Manager

Having joined Panacea in 2010, Sam’s role sees him developing the client relationships that Panacea are well-known for. With experience in a variety of roles at Panacea, Sam is uniquely placed to communicate on both a commercial and technical basis with clients. His ability to speak in plain language and understand detailed requirements, ensures that Panacea delivers on-time, every-time and maintains its current reputation as the leading, quality-focussed, pharmacovigilance and regulatory affairs provider.